Second-Gen Drug for HCM Emerges, Nipping at Mavacamten's Heels Novel cardiac myosin inhibitor is headed for a phase III trial Sep 12, 2021
Heart Failure's 'Golden Moment' Not Translating into Better Health Problems of implementation and health equity persist Sep 12, 2021
Feared ARNI Effect on Cognition Hasn't Come to Fruition Neurocognitive protection by sacubitril/valsartan suggested instead by observational study Sep 12, 2021
Overdiagnosis of Kidney Disease; Severity of the Delta Variant Also this week in TTHealthWatch: Tight blood pressure control and COVID sequelae at 6 months Sep 04, 2021 podcast
Topical Cream Effective Against Diabetic Foot Ulcers Investigational compound regulates macrophages, is "active-healing alternative," researchers say Sep 03, 2021
Good Results When Giving Flu Shots to MI Survivors Still in the Hospital Vaccination prior to discharge linked to heart benefit Aug 30, 2021
European CVD Prevention Guide Leans on Age Stratification Update has new risk assessment score but goes easy on blood pressure Aug 30, 2021
Lower BP Targets Again Affirmed in Major Trial STEP trial from China shows major benefits in older population Aug 30, 2021
Nonsteroidal MRA Drug Cuts Risks in Earlier Diabetic Kidney Disease Urine screening urged after trial shows benefit of treating cases with preserved kidney function Aug 29, 2021
Polypills Ready for Prime Time in Large Swaths of People, Researchers Say Question now is how to implement fixed-dose combo therapy in clinical practice Aug 29, 2021
His Bundle Pacing Stars in European Guidelines Revised edition could signal coming U.S. recommendations too Aug 29, 2021
Ablation, CRT Boost Survival in Permanent Afib With Narrow QRS APAF-CRT trial reinforces the case for expanded CRT indication Aug 28, 2021
Revamped Valve Disease Guideline: Europe Sees Nearly Eye to Eye With U.S. There is a different approach to deciding the suitability of TAVR, however Aug 28, 2021
A Familiar Drug Can Keep Early-Stage HCM at Bay Treatment with valsartan most beneficial when started early? Aug 27, 2021
Empagliflozin Improves Outcomes in HFpEF Patients "A major win" for heart failure with preserved ejection fraction, says editorialist Aug 27, 2021
New Heart Failure Guidelines Released, but Are They Already Out of Date? Results of EMPEROR-Preserved contradict guidance Aug 27, 2021
Milder Heart Failure Might Benefit From Implantable Monitors Randomized trial signals benefit, albeit hampered by the pandemic Aug 27, 2021
Deadly Arrhythmias Less of a Risk for HF Patients on Dapagliflozin DAPA-HF analysis further explores mechanism of SGLT2 inhibitor's heart benefits Aug 27, 2021
Heart Failure Again Takes Center Stage at ESC EMPEROR-Preserved, new guidelines, and more to come Aug 26, 2021
More and More U.S. Kids Being Diagnosed With Diabetes Rises seen in both type 1 and type 2 diabetes Aug 24, 2021
Kidney Disease No Barrier to Effient Benefit in ACS Trial analysis supports superiority over ticagrelor regardless of eGFR Aug 23, 2021
Kidney Transplant Outcomes Improved Over Past Quarter-Century Patient and graft survival rates have increased since 1996 Aug 18, 2021
Watch for Eye Problems in Kids Born to Mothers With Diabetes Any type of diabetes exposure in utero increased risk for high refractive error Aug 17, 2021
Pot Smokers Face Distinct Risks After Coronary Procedures But could marijuana use be associated with fewer cases of acute kidney injury? Aug 16, 2021
Combo GIP/GLP-1 Injectable Beats Insulin for A1c Reduction All doses of once-weekly tirzepatide better than insulin degludec for HbA1c reduction Aug 11, 2021
U.S. Kids Chowed Down on Highly Processed Foods Majority of energy intake came from ready-to-eat, ultraprocessed foods in 1999-2018 Aug 10, 2021
Are Hemoglobin Cutoffs for Anemia Outdated? A growing call for WHO criteria to be tightened Aug 06, 2021
Inotrope Showdown Leaves No Winner in Cardiogenic Shock Long-awaited head-to-head comparison of milrinone and dobutamine Aug 04, 2021
TAVR Debris Deflector Doesn't Fly With FDA Advisory Panel TriGuard 3 met with skepticism in its bid for approval Aug 04, 2021
Start Rhythm Control Early for Afib With Heart Failure EAST-AFNET 4 trial finds similar benefits across ejection fraction ranges Jul 31, 2021
FDA OKs First Interchangeable Insulin Biosimilar Semglee and Lantus insulin glargine products can now be swapped by pharmacists Jul 29, 2021
SGLT2 Inhibitor Adds Years of Life to Patients With Heart Failure DAPA-HF group makes projections as long-term data are lacking Jul 28, 2021
Shingrix OK'd for Immunocompromised Adults CDC's vaccine committee currently discussing vaccine for this population, manufacturer says Jul 26, 2021
Changes in Epicardial Fat May Drive SGLT2 Inhibitor Benefits More insight into mechanisms behind empagliflozin's cardioprotection Jul 26, 2021
Surprising Tradeoffs of Valve-in-Valve TAVR vs Redo Surgery Observational study suggests excess readmissions with less invasive procedure Jul 23, 2021
Doubling Semaglutide Dose Helps Get HbA1c Under Control But when is it time to add another agent to the mix? Jul 22, 2021
Does COAPT Change the Need to Try Foundational HF Drugs in Functional MR? Current GDMT titration approach under fire during TVT debate Jul 21, 2021
After Some Early Successes for Bicuspid TAVR, a Randomized Trial May Be Unlikely Are observational data on highly selected patients good enough? Jul 21, 2021
Spinal Cord Stimulation OK'd for Diabetic Nerve Pain First device of its kind to gain FDA approval for painful diabetic neuropathy Jul 19, 2021
Dexcom's CGM Interoperability Expands; Warfarin and Osteoporosis; Maine Bans PFAS News and commentary from the endocrinology world Jul 18, 2021
